Raymond James Financial’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.7M Buy
2,383,479
+485,142
+26% +$11.2M 0.02% 850
2026
Q1
$45.4M Buy
1,898,337
+495,893
+35% +$12.1M 0.01% 912
2025
Q4
$31.7M Buy
1,402,444
+98,286
+8% +$2.14M 0.01% 1124
2025
Q3
$26.3M Buy
1,304,158
+109,022
+9% +$1.83M 0.01% 1230
2025
Q2
$17.1M Buy
1,195,136
+243,345
+26% +$2.84M 0.01% 1487
2025
Q1
$9.99M Buy
951,791
+79,668
+9% +$901K ﹤0.01% 1810
2024
Q4
$10.6M Buy
+872,123
New +$11.4M ﹤0.01% 1805

Other funds holding ELAN

Raymond James Financial's ELAN Position: Q2 2026 in Review

Raymond James Financial increased its Elanco Animal Health (ELAN) stake by 26% in Q2 2026, buying an estimated $11.2M and bringing the position to 2,383,479 shares worth $58.7M. The position accounts for 0.02% of the portfolio, ranked #850.

Raymond James Financial first reported a position in ELAN in Q4 2024 and has held it in 7 quarters since. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Raymond James Financial held 2,383,479 shares of Elanco Animal Health worth $58.7M as of Q2 2026.
  • Raymond James Financial bought 485,142 Elanco Animal Health shares in Q2 2026, an estimated $11.2M.
  • Elanco Animal Health made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #850 holding.
  • Raymond James Financial first reported a position in Elanco Animal Health in Q4 2024 and has held it in 7 quarters since.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.